These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 28901643)
21. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review. Singhania G; Ejaz AA; McCullough PA; Kluger AY; Balamuthusamy S; Dass B; Singhania N; Agarwal A Rev Cardiovasc Med; 2019 Sep; 20(3):111-120. PubMed ID: 31601085 [TBL] [Abstract][Full Text] [Related]
22. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
23. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. Kalra PA; Kumwenda M; MacDowall P; Roland MO BMJ; 1999 Jan; 318(7178):234-7. PubMed ID: 9915733 [TBL] [Abstract][Full Text] [Related]
24. Management and monitoring of haemodynamic complications in acute heart failure. Aspromonte N; Cruz DN; Valle R; Ronco C Heart Fail Rev; 2011 Nov; 16(6):575-81. PubMed ID: 21301959 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin-converting enzyme inhibitors and renal function in heart failure. Dietz R; Nagel F; Osterziel KJ Am J Cardiol; 1992 Oct; 70(10):119C-125C. PubMed ID: 1329467 [TBL] [Abstract][Full Text] [Related]
27. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512 [TBL] [Abstract][Full Text] [Related]
28. Utility of Urine Biomarkers and Electrolytes for the Management of Heart Failure. Verbrugge FH Curr Heart Fail Rep; 2019 Dec; 16(6):240-249. PubMed ID: 31741232 [TBL] [Abstract][Full Text] [Related]
29. Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis. Hinton W; Feher MD; Munro N; Joy M; de Lusignan S Cardiovasc Diabetol; 2021 Jun; 20(1):130. PubMed ID: 34183018 [TBL] [Abstract][Full Text] [Related]
30. Evolution of renal function during and after an episode of cardiac decompensation: results from the Italian survey on acute heart failure. Tarantini L; Cioffi G; Gonzini L; Oliva F; Lucci D; Di Tano G; Maggioni AP; Tavazzi L; J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):234-43. PubMed ID: 19858732 [TBL] [Abstract][Full Text] [Related]
31. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors. Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571 [TBL] [Abstract][Full Text] [Related]
32. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure. Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934 [TBL] [Abstract][Full Text] [Related]
33. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology. Mewton N; Girerd N; Boffa JJ; Courivaud C; Isnard R; Juillard L; Lamblin N; Legrand M; Logeart D; Mariat C; Meune E; Sabouret P; Sebbag L; Rossignol P Arch Cardiovasc Dis; 2020 Oct; 113(10):660-670. PubMed ID: 32660835 [TBL] [Abstract][Full Text] [Related]
34. Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey. Dos Reis D; Fraticelli L; Bassand A; Manzo-Silberman S; Peschanski N; Charpentier S; Elbaz M; Savary D; Bonnefoy-Cudraz E; Laribi S; Henry P; Guerraoui A; Tazarourte K; Chouihed T; El Khoury C BMJ Open; 2019 Jan; 9(1):e022776. PubMed ID: 30782685 [TBL] [Abstract][Full Text] [Related]
36. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853 [TBL] [Abstract][Full Text] [Related]
37. Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis. Bridoux F; Hazzan M; Pallot JL; Fleury D; Lemaitre V; Kleinknecht D; Vanhille P Nephrol Dial Transplant; 1992; 7(2):100-4. PubMed ID: 1314966 [TBL] [Abstract][Full Text] [Related]
38. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
39. Diuretic treatment for the sodium retention of congestive heart failure. Cody RJ; Kubo SH; Pickworth KK Arch Intern Med; 1994 Sep; 154(17):1905-14. PubMed ID: 8074594 [TBL] [Abstract][Full Text] [Related]